The European Medicines Agency (EMA) has recommended that the use of Comirnaty, the COVID-19 vaccine produced by BioNTech/Pfizer, be extended to children aged between 5 and 11, the organisation said on Thursday.
EMA is suggesting using a lower dose of the vaccine for children between the ages of 5 and 11, than the dose used for people aged 12 and above (10 µg compared with 30 µg). The vaccine will be given as two injections, three weeks apart.
Source: Cyprus News Agency